Contemporary outcomes of sickle cell disease in pregnancy

American Journal of Obstetrics and Gynecology

Volumn 215, Issue 4, 2016, Pages 505.e1-505.e5

  Kuo, Kelly ^a   Caughey, Aaron B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

fetal anomalies; outcome; pregnancy; sickle cell disease

Indexed keywords

ADULT; ARTICLE; CESAREAN SECTION; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FETUS MALFORMATION; HUMAN; HYPERTENSION; INCIDENCE; LABOR INDUCTION; MAJOR CLINICAL STUDY; NORTH AMERICAN; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; SMALL FOR DATE INFANT; ABRUPTIO PLACENTAE; CALIFORNIA; CHILD DEATH; COMPLICATION; CONGENITAL ABNORMALITIES; GESTATIONAL AGE; INFANT; NEWBORN; OLIGOHYDRAMNIOS; PATHOPHYSIOLOGY; PERINATAL DEATH; PRE-ECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE BIRTH; PREMATURITY; STATISTICS AND NUMERICAL DATA; STILLBIRTH;

ABRUPTIO PLACENTAE; ADULT; ANEMIA, SICKLE CELL; CALIFORNIA; CESAREAN SECTION; COHORT STUDIES; CONGENITAL ABNORMALITIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT DEATH; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, SMALL FOR GESTATIONAL AGE; OLIGOHYDRAMNIOS; PERINATAL DEATH; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PREMATURE BIRTH; PRENATAL CARE; RETROSPECTIVE STUDIES; STILLBIRTH;

EID: 84994309500     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.05.032     Document Type: Article

References (22)

1. 1 Stuart, M.J., Nagel, R.L., Sickle-cell disease. Lancet 364 (2004), 1343–1360.
2. 2 Centers for Disease Control and Prevention. Sickle Cell Disease (SCD): Data & Statistics. 2015 7/8/2015 2/11/16]; Available from: http://www.cdc.gov/ncbddd/sicklecell/data.html. Accessed February 22, 2016.
3. 3 Hassell, K.L., Population estimates of sickle cell disease in the U.S. Am J Prev Med 38:suppl (2010), S512–S521.
4. 4 Boulet, S.L., Okoroh, E.M., Azonobi, I., Grant, A., Craig Hooper, W., Sickle cell disease in pregnancy: maternal complications in a Medicaid-enrolled population. Matern Child Health J 17 (2013), 200–207.
5. 5 Villers, M.S., Jamison, M.G., De Castro, L.M., James, A.H., Morbidity associated with sickle cell disease in pregnancy. Am J Obstet Gynecol 199 (2008), 125.e1–125.e5.
6. 6 Smith, J.A., Okoroh, E.M., Azonobi, I., Grant, A., Craig Hooper, W., Pregnancy in sickle cell disease: experience of the Cooperative Study of Sickle Cell Disease. Obstet Gynecol 87 (1996), 199–204.
7. 7 Boafor, T.K., Olayemi, E., Galadanci, N., et al. Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis. BJOG 123 (2016), 691–698.
8. 8 Alayed, N., Kezouh, A., Oddy, L., Abenhaim, H.A., Sickle cell disease and pregnancy outcomes: population-based study on 8.8 million births. J Perinat Med 42 (2014), 487–492.
9. 9 Odum, C.U., Anorlu, R.I., Dim, S.I., Oyekan, T.O., Pregnancy outcome in HbSS-sickle cell disease in Lagos, Nigeria. West Afr J Med 21 (2002), 19–23.
10. 10 Wilson, N.O., Ceesay, F.K., Hibbert, J.M., et al. Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study. Am J Trop Med Hyg 86 (2012), 936–942.
11. 11 Afolabi, B.B., Iwuala, N.C., Iwuala, I.C., Ogedengbe, O.K., Morbidity and mortality in sickle cell pregnancies in Lagos, Nigeria: a case control study. J Obstet Gynaecol 29 (2009), 104–106.
12. 12 Muganyizi, P.S., Kidanto, H., Sickle cell disease in pregnancy: trend and pregnancy outcomes at a tertiary hospital in Tanzania. PLoS One, 8, 2013, e56541.
13. 13 Barfield, W.D., Barradas, D.T., Manning, S.E., Kotelchuck, M., Shapiro-Mendoza, C.K., Sickle cell disease and pregnancy outcomes: women of African descent. Am J Prev Med 38:suppl (2010), S542–S549.
14. 14 Sun, P.M., Wilburn, W., Raynor, B.D., Jamieson, D., Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. Am J Obstet Gynecol 184 (2001), 1127–1130.
15. 15 Hutter, D., Kingdom, J., Jaeggi, E., Causes and mechanisms of intrauterine hypoxia and its impact on the fetal cardiovascular system: a review. Int J Pediatr, 2010, 2010, 9.
16. 16 Jauniaux, E., Watson, A.L., Hempstock, J., Bao, Y.P., Skepper, J.N., Burton, G.J., Onset of maternal arterial blood flow and placental oxidative stress: a possible factor in human early pregnancy failure. Am J Pathol 157 (2000), 2111–2122.
17. 17 Ba, S., Xiao, Y., Li, G., Casiano, C.A., Zhang, L., Effect of maternal chronic hypoxic exposure during gestation on apoptosis in fetal rat heart. Am J Physiol Heart Circ Physiol 285 (2003), H983–H990.
18. 18 Nichol, D., Stuhlmann, H., EGFL7: a unique angiogenic signaling factor in vascular development and disease. Blood 119 (2012), 1345–1352.
19. 19 Lane, P.A., Theodore, R.S., Quarmyne, M.O., Eckman, J.R., Zhou, M., Snyder, A.B., Accuracy of ICD-9 coding for SCD in children and adolescents: results from the Georgia (GA) Rush Surveillance Project. Blood, 124, 2014 4856-4856.
20. 20 Paulukonis, S.T., Harris, W.T., Coates, T.D., Neumayr, L., Treadwell, M., Vichinsky, E., Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH). Pediatr Blood Cancer 61 (2014), 2271–2276.
21. 21 Brousseau, D.C., Panepinto, J.A., Nimmer, M., Hoffmann, R.G., The number of people with sickle-cell disease in the United States: national and state estimates. Am J Hematol 85 (2010), 77–78.
22. 22 US Census Bureau; Census 2005: National Tables. Annual Estimates of the Population for the United States and States, and for Puerto Rico: April 1, 2000 to July 1, 2005 (NST-EST2005-01). Available at: http://www.census.gov/popest/data/historical/2000s/vintage_2005. Accessed May 6, 2016.